ENDPOINTS

Korean startup Curogen seeks US expansion, funding to back autoimmune drugs

A South Korean biotech working on multi-specific autoimmune disease treatments is looking to make a leap into the US. Curogen, based in Seoul and backed by local investors, announced Monday that it plans to open ...

Jun 2, 2025 - 13:04
 0
Korean startup Curogen seeks US expansion, funding to back autoimmune drugs
A South Korean biotech working on multi-specific autoimmune disease treatments is looking to make a leap into the US. Curogen, based in Seoul and backed by local investors, announced Monday that it plans to open ...
Read More

Tags:

Previous Article

A Neuralink Rival Just Tested a Brain Implant in a Person

Next Article

Phase 3 or bust: Why Lilly won't run mid-stage cancer trials

Related Posts

Novo Nordisk ‘strongly’ urges US away from pharma tariffs

Novo Nordisk ‘strongly’ urges US away from pharma tariffs

May 28, 2025  0

Roche’s 96-week data for multiple sclerosis drug; ZymeWorks claims $20M milestone

Roche’s 96-week data for multiple sclerosis drug; ZymeW...

May 30, 2025  0

#ASGCT25: In three patients, Rocket’s second heart gene therapy shows promise

#ASGCT25: In three patients, Rocket’s second heart gene...

May 16, 2025  0